BMC
NVAX icon

Bear Mountain Capital’s Novavax NVAX Stock Holding History

Bear Mountain Capital’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8 Hold
1
– – ﹤0.01% 212
2026
Q1 		$8 Hold
1
– – ﹤0.01% 196
2025
Q4 		$7 Hold
1
– – ﹤0.01% 198
2025
Q3 		$8 Hold
1
– – ﹤0.01% 322
2025
Q2 		$7 Hold
1
– – ﹤0.01% 182
2025
Q1 		$6 Hold
1
– – ﹤0.01% 342
2024
Q4 		$9 Hold
1
– – ﹤0.01% 174
2024
Q3 		$12 Hold
1
– – ﹤0.01% 171
2024
Q2 		$12 Hold
1
– – ﹤0.01% 178
2024
Q1 		$4 Sell
1
-18
-95% -$83 ﹤0.01% 222
2023
Q4 		$82 Buy
+19
New +$116 ﹤0.01% 220

Other funds holding NVAX

S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
OAM
OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Bear Mountain Capital's NVAX Position: Q2 2026 in Review

Bear Mountain Capital held its Novavax (NVAX) position steady in Q2 2026 at 1 share worth $8. The position accounts for ﹤0.01% of the portfolio, ranked #212.

Bear Mountain Capital first reported a position in NVAX in Q4 2023 and has held it in 11 quarters since. The position peaked at $82 in Q4 2023. 62 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Bear Mountain Capital held 1 share of Novavax worth $8 as of Q2 2026.
  • Bear Mountain Capital left its Novavax share count unchanged in Q2 2026.
  • Novavax made up ﹤0.01% of Bear Mountain Capital's portfolio in Q2 2026, its #212 holding.
  • Bear Mountain Capital first reported a position in Novavax in Q4 2023 and has held it in 11 quarters since.
  • Bear Mountain Capital's Novavax position peaked at $82 in Q4 2023.
  • 62 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Bear Mountain Capital's 13F filing for Q2 2026, filed 20 Jul 2026.